M72.4
Pseudosarcomatous fibromatosis
Clinical Classification Guidelines
Inclusion Terms
- Nodular fasciitis
Medical Intelligence & Overview
Pseudosarcomatous fibromatosis, also known as nodular fasciitis, is a benign but rapidly growing soft tissue condition that often mimics more serious cancerous tumors. Recognized under the ICD-10 code M72.4, this condition typically affects young adults and can occur in various parts of the body. Although it may appear alarming due to its quick growth, it is generally a harmless lesion that responds well to treatment. Understanding its features can help in distinguishing it from malignant tumors and ensure appropriate management.
Causes & Symptoms
Clinical Causes: Unknown exact cause; believed to be a reactive process possibly triggered by minor trauma or injury Genetic factors might play a role in some cases Rapid cell proliferation in response to local injury or inflammation
Key Symptoms: Sudden appearance of a firm, palpable lump or mass Rapid growth over weeks to a few months Pain or tenderness in some cases Possible redness or warmth if inflammation occurs
Diagnostic & Treatment
Diagnosis Path: Physical examination revealing a well-defined, movable mass Imaging tests such as ultrasound or MRI to assess the size, location, and characteristics of the lesion Biopsy for histological analysis, showing spindle-shaped cells in a myxoid stroma without malignant features
Treatment Protocols: Complete surgical excision with clear margins to reduce recurrence risk Observation if the lesion is small, asymptomatic, and diagnosis is certain Less commonly, corticosteroids or other medications may be used in certain cases Regular follow-up post-treatment to monitor for recurrence, which is uncommon
Clinical Advice & FAQs
Billing Guidance
Is M72.4 a billable ICD-10 code?
Yes, M72.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M72.4?
Clinical documentation must specify the nature of Pseudosarcomatous fibromatosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
